DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Yoshimura N, Watanabe M, Motoya S. et al
Safety and Efficacy of AJM300, an Oral Antagonist of alpha4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis.
Gastroenterology 2015;
149: 1775-1783 e1772
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.